{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T07:20:33Z","timestamp":1774509633350,"version":"3.50.1"},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006633","name":"Bowling Green State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>More than 100,000 preventable deaths have occurred each year in the United States since 2021 from intravenous drug use. A challenging problem for clinicians, researchers, and public health workers involves understanding a dynamic opioid crisis for implementing state and national policy to support the rehabilitation and treatment of individuals who inject drugs. To address these issues, this study used drug needles obtained from people who inject drugs to address three goals: First, based on a forensic analysis, what narcotics are contained in the needles? Second, are there non-viral pathogens contained in the needles? Third, if pathogens are identified, can potential infections be treated with common medication? Results demonstrate that 27 total psychoactive substances (most listed in the Drug Enforcement Administration\u2019s schedule of controlled substances) were present in 50 randomly selected syringes. The average used drug needle contained eight psychoactive substances. In addition to drugs, non-viral culturable microbes in used syringes were identified. The most problematic of these was an opportunistic fungal pathogen, <jats:italic><jats:italic>Candida parapsilosis<\/jats:italic><\/jats:italic>, that persists on skin and for which few medical options exist for treatment. To thus facilitate antifungal discovery, soil-derived bacteria that inhibit the growth of <jats:italic><jats:italic>Candida<\/jats:italic><\/jats:italic> pathogens were identified. Transposon mutagenesis was utilized to discover the biosynthetic gene cluster involved in antifungal activity which encoded a non-ribosomal peptide synthetase. Although limited to syringes from only one mid-western city, results suggest that potentially fatal, emergent, and opportunistic pathogens may have the ability to persist in used drug syringes. While this finding may be alarming to public health and public safety officials, the identification of bacteria which inhibits the growth of <jats:italic><jats:italic>Candida parapsilosis<\/jats:italic><\/jats:italic> poses a foundation for antifungal drug discovery.<\/jats:p>","DOI":"10.1371\/journal.pone.0326200","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T17:40:46Z","timestamp":1755020446000},"page":"e0326200","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Opportunistic pathogens and polycocktail drugs fuel dynamic public health threats during the opioid crisis"],"prefix":"10.1371","volume":"20","author":[{"given":"John H.","family":"Boman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nara","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2506-5073","authenticated-orcid":true,"given":"Jasmine","family":"Light","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawson","family":"Holt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelic","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahjida","family":"Berryman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Shuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry K.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda L. A.","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3723-3820","authenticated-orcid":true,"given":"Hans","family":"Wildschutte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"pone.0326200.ref001","volume-title":"Drug overdose deaths in the U.S. top 100,000 annually","author":"CDC NCfHS","year":"2021"},{"key":"pone.0326200.ref002","volume-title":"Top 10 preventable injuries","author":"Council NS","year":"2023"},{"key":"pone.0326200.ref003","volume-title":"Overdose prevention","author":"CDC","year":"2024"},{"issue":"9810","key":"pone.0326200.ref004","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(11)61674-7","article-title":"Drug policy and the public good: evidence for effective interventions","volume":"379","author":"J Strang","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"pone.0326200.ref005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1086\/670818","article-title":"Why Has US Drug Policy Changed So Little over 30 Years?","volume":"42","author":"P Reuter","year":"2013","journal-title":"Crime and Justice"},{"key":"pone.0326200.ref006","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugpo.2018.02.006","article-title":"Federal funding for syringe exchange in the US: Explaining a long-term policy failure","volume":"55","author":"D Showalter","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"5","key":"pone.0326200.ref007","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/23744235.2020.1727002","article-title":"Significant decrease in injection risk behaviours among participants in a needle exchange programme","volume":"52","author":"M K\u00e5berg","year":"2020","journal-title":"Infect Dis (Lond)"},{"issue":"5","key":"pone.0326200.ref008","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(21)00013-X","article-title":"Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis","volume":"6","author":"C Arum","year":"2021","journal-title":"Lancet Public Health"},{"key":"pone.0326200.ref009","volume-title":"Drug overdose mortality by state","author":"CDC NCfHS","year":"2024"},{"key":"pone.0326200.ref010","volume-title":"Quick facts. Lucas County, Ohio","author":"U.S. Census Bureau","year":"2024"},{"key":"pone.0326200.ref011","volume-title":"Unintentional drug overdose report","author":"Health ODo","year":"2023"},{"key":"pone.0326200.ref012","volume-title":"Opportunity zones","author":"Servic USIR","year":"2024"},{"key":"pone.0326200.ref013","volume-title":"Uniform crime reports, crime in the United States","author":"Investigation FBo","year":"2024"},{"key":"pone.0326200.ref014","volume-title":"Unemployment rate in Lucas County, OH","author":"Reserve F","year":"2024"},{"key":"pone.0326200.ref015","volume-title":"Income and poverty: Lucas County, OH.","author":"Bureau USC","year":"2024"},{"key":"pone.0326200.ref016","volume-title":"Northwest Ohio Syringe Services","author":"Department T-LCH","year":"2024"},{"issue":"2","key":"pone.0326200.ref017","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s12010-012-0043-8","article-title":"An extremely simple and effective colony PCR procedure for bacteria, yeasts, and microalgae","volume":"169","author":"H Packeiser","year":"2013","journal-title":"Appl Biochem Biotechnol"},{"issue":"47","key":"pone.0326200.ref018","first-page":"2437","article-title":"Microtiter dish biofilm formation assay","author":"GA O\u2019Toole","year":"2011","journal-title":"J Vis Exp"},{"issue":"8","key":"pone.0326200.ref019","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/bioinformatics\/btt086","article-title":"QUAST: quality assessment tool for genome assemblies","volume":"29","author":"A Gurevich","year":"2013","journal-title":"Bioinformatics"},{"issue":"5","key":"pone.0326200.ref020","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41587-019-0072-8","article-title":"Assembly of long, error-prone reads using repeat graphs","volume":"37","author":"M Kolmogorov","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"11","key":"pone.0326200.ref021","first-page":"000685","article-title":"Bakta: rapid and standardized annotation of bacterial genomes via alignment-free sequence identification","volume":"7","author":"O Schwengers","year":"2021","journal-title":"Microb Genom"},{"key":"pone.0326200.ref022","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkp848","article-title":"The Genomes On Line Database (GOLD) in 2009: status of genomic and metagenomic projects and their associated metadata","volume":"38","author":"K Liolios","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"23","key":"pone.0326200.ref023","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.01438-19","article-title":"Loci Encoding Compounds Potentially Active against Drug-Resistant Pathogens amidst a Decreasing Pool of Novel Antibiotics","volume":"85","author":"J Basalla","year":"2019","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"pone.0326200.ref024","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mimet.2005.02.011","article-title":"An improved arbitrary primed PCR method for rapid characterization of transposon insertion sites","volume":"63","author":"S Das","year":"2005","journal-title":"J Microbiol Methods"},{"key":"pone.0326200.ref025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2180-11-38","article-title":"pBAM1: an all-synthetic genetic tool for analysis and construction of complex bacterial phenotypes","volume":"11","author":"E Mart\u00ednez-Garc\u00eda","year":"2011","journal-title":"BMC Microbiol"},{"key":"pone.0326200.ref026","volume-title":"The growing threat of xylazine and its mixture with illicit drugs: DEA joint intelligence report","author":"U.S. Department of Justice DEA","year":"2022"},{"issue":"8","key":"pone.0326200.ref027","article-title":"Xylazine-Induced Skin Ulcers in a Person Who Injects Drugs in Philadelphia, Pennsylvania, USA","volume":"14","author":"SV Malayala","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"pone.0326200.ref028","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrmicro.2017.157","article-title":"The human skin microbiome","volume":"16","author":"AL Byrd","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"pone.0326200.ref029","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa008","article-title":"Bacterial Infections Associated With Substance Use Disorders, Large Cohort of United States Hospitals, 2012-2017","volume":"71","author":"NL McCarthy","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pone.0326200.ref030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12954-022-00624-6","article-title":"Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage","volume":"19","author":"A Hrycko","year":"2022","journal-title":"Harm Reduct J"},{"issue":"1","key":"pone.0326200.ref031","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/jof9010080","article-title":"Candida parapsilosis Virulence and Antifungal Resistance Mechanisms: A Comprehensive Review of Key Determinants","volume":"9","author":"J Branco","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"pone.0326200.ref032","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/CMR.00013-08","article-title":"Candida parapsilosis, an emerging fungal pathogen","volume":"21","author":"D Trofa","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"pone.0326200.ref033","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa024","article-title":"Injection Drug Use-Associated Candidemia: Incidence, Clinical Features, and Outcomes, East Tennessee, 2014-2018","volume":"222","author":"JA Rossow","year":"2020","journal-title":"J Infect Dis"},{"issue":"4","key":"pone.0326200.ref034","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3201\/eid2404.171807","article-title":"Reemergence of intravenous drug use as risk factor for Candidemia, Massachusetts, USA","volume":"24","author":"N Poowanawittayakom","year":"2018","journal-title":"Emerging infectious diseases"},{"issue":"12","key":"pone.0326200.ref035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.15585\/mmwr.mm6812a3","article-title":"Candida Bloodstream Infections Among Persons Who Inject Drugs - Denver Metropolitan Area, Colorado, 2017-2018","volume":"68","author":"DM Barter","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"pone.0326200.ref036","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/cid\/ciz1061","article-title":"The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor-Active Surveillance in Selected Sites, United States, 2014-2017","volume":"71","author":"AY Zhang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"pone.0326200.ref037","volume-title":"World Health Organization fungal priority pathogens list to guide research, development and public health action","author":"Division AR","year":"2022"},{"issue":"2","key":"pone.0326200.ref038","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/ciab336","article-title":"Mortality Trends in Risk Conditions and Invasive Mycotic Disease in the United States, 1999-2018","volume":"74","author":"E Rayens","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pone.0326200.ref039","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision","volume":"3","author":"F Bongomin","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"pone.0326200.ref040","unstructured":"Health P. Outbreak and containment of Candida auris in PA healthcare facilities. 2023."},{"key":"pone.0326200.ref041","unstructured":"Wcdeae. Candida auris outbreak in a King County WA healthcare facility. 2024."},{"issue":"10","key":"pone.0326200.ref042","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1128\/JCM.42.10.4468-4472.2004","article-title":"Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital","volume":"42","author":"TA Clark","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"3","key":"pone.0326200.ref043","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/healthcare11030425","article-title":"Candida auris as an Emergent Public Health Problem: A Current Update on European Outbreaks and Cases","volume":"11","author":"N Geremia","year":"2023","journal-title":"Healthcare (Basel)"},{"issue":"6","key":"pone.0326200.ref044","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00067-8","article-title":"Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap","volume":"4","author":"F Daneshnia","year":"2023","journal-title":"Lancet Microbe"},{"key":"pone.0326200.ref045","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment","volume":"216","author":"MC Arendrup","year":"2017","journal-title":"J Infect Dis"},{"key":"pone.0326200.ref046","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/IDR.S124918","article-title":"Antifungal resistance: current trends and future strategies to combat","volume":"10","author":"NP Wiederhold","year":"2017","journal-title":"Infect Drug Resist"},{"issue":"1","key":"pone.0326200.ref047","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s44259-023-00007-2","article-title":"Molecular mechanisms governing antifungal drug resistance","volume":"1","author":"Y Lee","year":"2023","journal-title":"NPJ Antimicrob Resist"},{"issue":"4","key":"pone.0326200.ref048","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1574-6976.2011.00269.x","article-title":"Pseudomonas genomes: diverse and adaptable","volume":"35","author":"MW Silby","year":"2011","journal-title":"FEMS Microbiol Rev"},{"issue":"11","key":"pone.0326200.ref049","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1039\/b817075b","article-title":"Genomics of secondary metabolite production by Pseudomonas spp","volume":"26","author":"H Gross","year":"2009","journal-title":"Nat Prod Rep"},{"key":"pone.0326200.ref050","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr466","article-title":"antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences","volume":"39","author":"MH Medema","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"pone.0326200.ref051","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41570-023-00463-4","article-title":"Metals to combat antimicrobial resistance","volume":"7","author":"A Frei","year":"2023","journal-title":"Nat Rev Chem"},{"key":"pone.0326200.ref052","volume-title":"DEA reports widespread threat of fentanyl mixed with xylazine","author":"U.S. Department of Justice DIA","year":"2021"},{"key":"pone.0326200.ref053","doi-asserted-by":"crossref","first-page":"109380","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"J Friedman","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"pone.0326200.ref054","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00430373","article-title":"Physiology of yeasts in relation to biomass yields","volume":"60","author":"C Verduyn","year":"1991","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"6","key":"pone.0326200.ref055","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1360-0443.2009.02887.x","article-title":"Ambient temperature and risk of death from accidental drug overdose in New York City, 1990-2006","volume":"105","author":"ASB Bohnert","year":"2010","journal-title":"Addiction"},{"key":"pone.0326200.ref056","volume-title":"Trends in toxic adulterants in street drugs in the United States","author":"Education CfFSR,","year":"2024"},{"issue":"5","key":"pone.0326200.ref057","doi-asserted-by":"crossref","first-page":"799","DOI":"10.15288\/jsad.2018.79.799","article-title":"Polysubstance Use by Stimulant Users: Health Outcomes Over Three Years","volume":"79","author":"C Timko","year":"2018","journal-title":"J Stud Alcohol Drugs"},{"issue":"8","key":"pone.0326200.ref058","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/JPER.19-0509","article-title":"Cocaine, polysubstance abuse, and oral health outcomes, NHANES 2009 to 2014","volume":"91","author":"D Bahdila","year":"2020","journal-title":"J Periodontol"},{"key":"pone.0326200.ref059","volume-title":"Substance use and HIV risk","author":"Minority HIV\/AIDS Fund Hg","year":"2023"},{"issue":"12","key":"pone.0326200.ref060","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/s41564-023-01512-w","article-title":"Global warming could drive the emergence of new fungal pathogens","volume":"8","author":"A Casadevall","year":"2023","journal-title":"Nat Microbiol"},{"issue":"2","key":"pone.0326200.ref061","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00360-21","article-title":"Environmental Candida auris and the Global Warming Emergence Hypothesis","volume":"12","author":"A Casadevall","year":"2021","journal-title":"mBio"},{"issue":"6","key":"pone.0326200.ref062","doi-asserted-by":"crossref","first-page":"143","DOI":"10.15698\/mic2020.06.718","article-title":"Fungal infections in humans: the silent crisis","volume":"7","author":"K Kainz","year":"2020","journal-title":"Microb Cell"},{"issue":"7","key":"pone.0326200.ref063","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"DW Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"pone.0326200.ref064","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00053-22","article-title":"Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents","volume":"66","author":"SE Jacobs","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"14","key":"pone.0326200.ref065","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1039\/C4DT03559C","article-title":"Beyond iron: non-classical biological functions of bacterial siderophores","volume":"44","author":"TC Johnstone","year":"2015","journal-title":"Dalton Trans"},{"issue":"1","key":"pone.0326200.ref066","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1038\/s41467-023-40828-3","article-title":"Metallo-sideromycin as a dual functional complex for combating antimicrobial resistance","volume":"14","author":"C Wang","year":"2023","journal-title":"Nat Commun"},{"issue":"3","key":"pone.0326200.ref067","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40265-019-1055-2","article-title":"Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli","volume":"79","author":"GG Zhanel","year":"2019","journal-title":"Drugs"},{"issue":"12","key":"pone.0326200.ref068","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/phar.2476","article-title":"Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug-Resistant Gram-Negative Pathogens","volume":"40","author":"JC Abdul-Mutakabbir","year":"2020","journal-title":"Pharmacotherapy"},{"key":"pone.0326200.ref069","doi-asserted-by":"crossref","first-page":"1143861","DOI":"10.3389\/fmicb.2023.1143861","article-title":"Two new siderophores produced by Pseudomonas sp. NCIMB 10586: The anti-oomycete non-ribosomal peptide synthetase-dependent mupirochelin and the NRPS-independent triabactin","volume":"14","author":"C Grosse","year":"2023","journal-title":"Front Microbiol"},{"issue":"4","key":"pone.0326200.ref070","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10534-022-00480-8","article-title":"Iron acquisition strategies in pseudomonads: mechanisms, ecology, and evolution","volume":"36","author":"R K\u00fcmmerli","year":"2023","journal-title":"Biometals"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0326200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T17:40:56Z","timestamp":1755020456000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0326200"}},"subtitle":[],"editor":[{"given":"Ant\u00f3nio","family":"Machado","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":70,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0326200","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}